1.    Yasmeen F, Pirzada RH, Ahmad B, Choi B, Choi S. Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies. International journal of molecular sciences. 2024;25(14).
2.    Goswami TK, Singh M, Dhawan M, Mitra S, Emran TB, Rabaan AA, et al. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges. Human vaccines & immunotherapeutics. 2022;18(1):2035117.
3.    Bernatsky S, Smargiassi A, Johnson M, Kaplan GG, Barnabe C, Svenson L, et al. Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta. Environmental research. 2015;140:474-8.
4.    Kubatka P, Bojkova B, Nosalova N, Huniadi M, Samuel SM, Sreenesh B, et al. Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients. EPMA Journal. 2025;16(2):437-63.
5.    Frazzei G, van Vollenhoven RF, de Jong BA, Siegelaar SE, van Schaardenburg D. Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes. Frontiers in immunology. 2022;13:899372.
6.    Lee CE, Singleton KS, Wallin M, Faundez V. Rare Genetic Diseases: Nature’s Experiments on Human Development. iScience. 2020;23(5):101123.
7.    Medhasi S, Chantratita N. Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections. Journal of immunology research. 2022;2022:9710376.
8.    Shetty SS, D D, S H, Sonkusare S, Naik PB, Kumari N S, et al. Environmental pollutants and their effects on human health. Heliyon. 2023;9(9):e19496.
9.    Cheng Y, Yang Y, Bai L, Cui J. Microplastics: an often-overlooked issue in the transition from chronic inflammation to cancer. Journal of translational medicine. 2024;22(1):959.
10.Song Y, Li J, Wu Y. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduction and Targeted Therapy. 2024;9(1):263.
11.Stefanicka-Wojtas D, Kurpas D. Personalised Medicine-Implementation to the Healthcare System in Europe (Focus Group Discussions). Journal of personalized medicine. 2023;13(3).
12.Drago G, Aloi N, Ruggieri S, Longo A, Contrino ML, Contarino FM, et al. Guardians under Siege: Exploring Pollution’s Effects on Human Immunity. International journal of molecular sciences [Internet]. 2024; 25(14).
13.Alotiby A. Immunology of Stress: A Review Article. Journal of clinical medicine. 2024;13(21).
14.Harshitha P, Bose K, Dsouza HS. Influence of lead-induced toxicity on the inflammatory cytokines. Toxicology. 2024;503:153771.
15.Chandimali N, Bak SG, Park EH, Lim H-J, Won Y-S, Kim E-K, et al. Free radicals and their impact on health and antioxidant defenses: a review. Cell Death Discovery. 2025;11(1):19.
16.Kowalczyk P, Sulejczak D, Kleczkowska P, Bukowska-Ośko I, Kucia M, Popiel M, et al. Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases. International journal of molecular sciences. 2021;22(24).
17.Kanwugu ON, Glukhareva TV. Activation of Nrf2 pathway as a protective mechanism against oxidative stress-induced diseases: Potential of astaxanthin. Archives of Biochemistry and Biophysics. 2023;741:109601.
18.Goshtasbi H, Hashemzadeh N, Fathi M, Movafeghi A, Barar J, Omidi Y. Mitigating oxidative stress toxicities of environmental pollutants by antioxidant nanoformulations. Nano TransMed. 2025;4:100087.
19.Danieli MG, Casciaro M, Paladini A, Bartolucci M, Sordoni M, Shoenfeld Y, et al. Exposome: Epigenetics and autoimmune diseases. Autoimmunity Reviews. 2024;23(6):103584.
20.Mukherjee S, Dasgupta S, Mishra PK, Chaudhury K. Air pollution-induced epigenetic changes: disease development and a possible link with hypersensitivity pneumonitis. Environmental science and pollution research international. 2021;28(40):55981-6002.
21.Xiang Y, Zhang M, Jiang D, Su Q, Shi J. The role of inflammation in autoimmune disease: a therapeutic target. Frontiers in immunology. 2023;14:1267091.
22.Trivadila T, Iswantini D, Rahminiwati M, Rafi M, Salsabila AP, Sianipar RN, et al. Herbal Immunostimulants and Their Phytochemicals: Exploring Morinda citrifolia, Echinacea purpurea, and Phyllanthus niruri. Plants [Internet]. 2025; 14(6).
23.Lai S, Wu X, Liu Y, Liu B, Wu H, Ma K.Interaction between Th17 and central nervous system in multiple sclerosis. Brain, Behavior, & Immunity - Health. 2025;43:100928.
24.Abianeh HS, Kesharwani P, Sahebkar A. The use of aptamers as therapeutic inhibitors and biosensors of TNF-alpha. International Journal of Biological Macromolecules. 2025;306:141202.
25.Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. International journal of molecular sciences. 2021;22(5).
26.Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, et al. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharmacotherapy. 2023;168:115734.
27.Jagirdhar GSK, Perez JA, Perez AB, Surani S. Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease. World journal of gastroenterology. 2023;29(36):5211-25.
28.Pondman K, Le Gac S, Kishore U. Nanoparticle-induced immune response: Health risk versus treatment opportunity? Immunobiology. 2023;228(2):152317.
29.Mashayekhi K, Khazaie K, Faubion WA, Kim GB. Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment. Bioactive Materials. 2024;37:269-98.
30.Schlöder J, Shahneh F, Schneider F-J, Wieschendorf B. Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle! 2022;Volume 13 - 2022.
31.Hassan M, Elzallat M, Mohammed DM, Balata M, El-Maadawy WH. Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases. International Immunopharmacology. 2025;155:114624.
32.Li Y, Liu H, Yan H, Xiong J. Research advances on targeted-Treg therapies on immune-mediated kidney diseases. Autoimmunity Reviews. 2023;22(2):103257.
33.Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, et al. Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics. 2024;16(3).
34.Alengebawy A, Abdelkhalek ST, Qureshi SR, Wang MQ. Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications. Toxics. 2021;9(3).
35.Abdulraheem MI, Xiong Y, Moshood AY, Cadenas-Pliego G, Zhang H, Hu J. Mechanisms of Plant Epigenetic Regulation in Response to Plant Stress: Recent Discoveries and Implications. Plants (Basel, Switzerland). 2024;13(2).
36.Unar A, Qureshi M, Afridi HI, Wassan S. The Role of Bacterial Toxins and Environmental Factors in the Development of Food Allergies. Allergies [Internet]. 2024; 4(4):[192-217 pp.].
37.Parvin N, Joo SW, Mandal TK. Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases. Journal of functional biomaterials. 2025;16(1).
38.Kharrazian D. Exposure to Environmental Toxins and Autoimmune Conditions. Integrative medicine (Encinitas, Calif). 2021;20(2):20-4.
39.Danieli MG, Brunetto S, Gammeri L, Palmeri D, Claudi I, Shoenfeld Y, et al. Machine learning application in autoimmune diseases: State of art and future prospectives. Autoimmunity Reviews. 2024;23(2):103496.
40.Su J, Yang L, Sun Z, Zhan X. Personalized Drug Therapy: Innovative Concept Guided With Proteoformics. Molecular & cellular proteomics : MCP. 2024;23(3):100737.
41.Li Y, Chen B, Yang S, Jiao Z, Zhang M, Yang Y, et al. Advances in environmental pollutant detection techniques: Enhancing public health monitoring and risk assessment. Environment International. 2025;197:109365.
42.Mpakosi A, Cholevas V, Tzouvelekis I, Passos I, Kaliouli-Antonopoulou C, Mironidou-Tzouveleki M. Autoimmune Diseases Following Environmental Disasters: A Narrative Review of the Literature. Healthcare (Basel, Switzerland). 2024;12(17).
43.Mitra S, Chakraborty AJ, Tareq AM, Emran TB, Nainu F, Khusro A, et al. Impact of heavy metals on the environment and human health: Novel therapeutic insights to counter the toxicity. Journal of King Saud University - Science. 2022;34(3):101865.
44.Yasmeen F, Pirzada RH, Ahmad B, Choi B, Choi S. Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies. International journal of molecular sciences [Internet]. 2024; 25(14).
45.Metryka E, Chibowska K, Gutowska I, Falkowska A, Kupnicka P, Barczak K, et al. Lead (Pb) Exposure Enhances Expression of Factors Associated with Inflammation. International journal of molecular sciences. 2018;19(6).
46.Christodoulou M, Moysidou E, Lioulios G, Stai S, Lazarou C, Xochelli A, et al. T-Follicular Helper Cells and Their Role in Autoimmune Diseases. Life (Basel, Switzerland). 2025;15(4).
47.Haidar Z, Fatema K, Shoily SS, Sajib AA. Disease-associated metabolic pathways affected by heavy metals and metalloid. Toxicology reports. 2023;10:554-70.
48.Hemdan NY, Abu El-Saad AM, Sack U. The role of T helper (TH)17 cells as a double-edged sword in the interplay of infection and autoimmunity with a focus on xenobiotic-induced immunomodulation. Clinical & developmental immunology. 2013;2013:374769.
49.Rasin P, V AA, Basheer SM, Haribabu J, Santibanez JF, Garrote CA, et al. Exposure to cadmium and its impacts on human health: A short review. Journal of Hazardous Materials Advances. 2025;17:100608.
50.Knoell DL, Wyatt TA. The adverse impact of cadmium on immune function and lung host defense. Seminars in cell & developmental biology. 2021;115:70-6.
51.Rajendeeran A, Tenbrock K. Regulatory T cell function in autoimmune disease. Journal of translational autoimmunity. 2021;4:100130.
52.Duan X, Xu G, Li J, Yan N, Li X, Liu X, et al. Arsenic Induces Continuous Inflammation and Regulates Th1/Th2/Th17/Treg Balance in Liver and Kidney In Vivo. Mediators of inflammation. 2022;2022:8414047.
53.Serafini MM, Maddalon A, Iulini M, Galbiati V. Air Pollution: Possible Interaction between the Immune and Nervous System? International journal of environmental research and public health. 2022;19(23).
54.Moudgil KD, Venkatesha SH. The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. International journal of molecular sciences [Internet]. 2023; 24(1).
55.Glencross DA, Ho T-R, Camiña N, Hawrylowicz CM, Pfeffer PE. Air pollution and its effects on the immune system. Free Radical Biology and Medicine. 2020;151:56-68.
56.Nasb M, Li F, Dayoub L, Wu T, Wei M, Chen N. Bridging the gap: Integrating exercise mimicry into chronic disease management through suppressing chronic inflammation. Journal of Advanced Research. 2025;70:307-22.
57.Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18.
58.Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR. Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Frontiers in immunology. 2018;9:2379.
59.Xuan S, Ma Y, Zhou H, Gu S, Yao X, Zeng X. The implication of dendritic cells in lung diseases: Immunological role of toll-like receptor 4. Genes & Diseases. 2024;11(6):101007.
60.Zhang P, Martin M, Michalek SM, Katz J. Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B. Infection and immunity. 2005;73(7):3990-8.
61.Andretto V, Dusi S, Zilio S, Repellin M, Kryza D, Ugel S, et al. Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines. Advanced Drug Delivery Reviews. 2023;201:115080.
62.Richter P, Macovei LA, Mihai IR, Cardoneanu A, Burlui MA, Rezus E. Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17. International journal of molecular sciences [Internet]. 2023; 24(19).
63.Lopetuso LR, Cuomo C, Mignini I, Gasbarrini A, Papa A. Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases. International journal of molecular sciences [Internet]. 2023; 24(9).
64.Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scandinavian journal of pain. 2017;17:287-93.
65.Tylutka A, Walas Ł, Zembron-Lacny A. Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis. 2024;Volume 15 - 2024.
66.Nie J, Zhou L, Tian W, Liu X, Yang L, Yang X, et al. Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduction and Targeted Therapy. 2025;10(1):112.
67.Quinn JL, Kumar G, Agasing A, Ko RM, Axtell RC. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. 2018;Volume 9 - 2018.
68.Xie G, Chen X, Gao Y, Yang M, Zhou S, Lu L, et al. Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications. Clinical Reviews in Allergy & Immunology. 2025;68(1):18.
69.Wei J, Zhang Y, Li H, Wang F, Yao S. Toll-like receptor 4: A potential therapeutic target for multiple human diseases. Biomedicine & Pharmacotherapy. 2023;166:115338.
70.Wang G, Su Z, Li H, Xiao L, Li C, Lian G. The role of metabolism in Th17 cell differentiation and autoimmune diseases. International Immunopharmacology. 2022;103:108450.
71.Jang D-i, Lee AH, Shin H-Y, Song H-R, Park J-H, Kang T-B, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. International journal of molecular sciences [Internet]. 2021; 22(5).
72.Strzelec M, Detka J, Mieszczak P, Sobocińska MK, Majka M. Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Frontiers in immunology. 2023;14:1127704.
73.Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Seminars in immunology. 2013;25(6):469-84.
74.Favalli EG. Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis. Rheumatology and therapy. 2020;7(3):473-516.
75.Bi Y, Yang R. Direct and Indirect Regulatory Mechanisms in TH17 cell Differentiation and Functions. 2012;75(6):543-52.
76.Soares-Silva M, Diniz FF, Gomes GN, Bahia D. The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids. 2016;Volume 7 - 2016.
77.Ahmadi A, Ahrari S, Salimian J, Salehi Z, Karimi M, Emamvirdizadeh A, et al. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. Cell communication and signaling : CCS. 2023;21(1):314.
78.Vilas-Boas V, Chatterjee N, Carvalho A, Alfaro-Moreno E. Particulate matter-induced oxidative stress – Mechanistic insights and antioxidant approaches reported in in vitro studies. Environmental Toxicology and Pharmacology. 2024;110:104529.
79.Canton M, Sánchez-Rodríguez R, Spera I, Venegas FC, Favia M, Viola A, et al. Reactive Oxygen Species in Macrophages: Sources and Targets. Frontiers in immunology. 2021;12:734229.
80.Zheng X, Sawalha AH. The Role of Oxidative Stress in Epigenetic Changes Underlying Autoimmunity. Antioxidants & redox signaling. 2022;36(7-9):423-40.
81.Khan MF, Wang H. Environmental Exposures and Autoimmune Diseases: Contribution of Gut Microbiome. Frontiers in immunology. 2019;10:3094.
82.Zhao C-N, Xu Z, Wu G-C, Mao Y-M, Liu L-N, Qian W, et al. Emerging role of air pollution in autoimmune diseases. Autoimmunity Reviews. 2019;18(6):607-14.
83.Jee Y-M, Lee J-Y, Ryu T. Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma. Biomedicines [Internet]. 2025; 13(5).
84.Rio P, Gasbarrini A, Gambassi G, Cianci R. Pollutants, microbiota and immune system: frenemies within the gut. Frontiers in public health. 2024;12:1285186.
85.Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases. Genes Dis. 2021;8(3):287-97.
86.Bauer RN, Diaz-Sanchez D, Jaspers I. Effects of air pollutants on innate immunity: the role of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors. The Journal of allergy and clinical immunology. 2012;129(1):14-24; quiz 5-6.
87.Kany S, Vollrath JT, Relja B. Cytokines in Inflammatory Disease. International journal of molecular sciences. 2019;20(23).
88.Galeano-Sánchez D, Morales-González V, Monsalve DM, Ramırez-Santana C, Acosta-Ampudia Y. Airborne culprits: A comprehensive review of PM, silica, and TCDD in autoimmune diseases. Journal of translational autoimmunity. 2024;9:100253.
89.Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research. 2002;12(1):9-18.
90.Zhang K. Environmental PM(2.5)-triggered stress responses in digestive diseases. eGastroenterology. 2024;2(2).
91.Lin F-x, Gu H-y, He W. MAPK signaling pathway in spinal cord injury: Mechanisms and therapeutic potential. Experimental Neurology. 2025;383:115043.
92.Alam MS, Gaida MM, Ogawa Y, Kolios AG, Lasitschka F, Ashwell JD. Counter-regulation of T cell effector function by differentially activated p38. The Journal of experimental medicine. 2014;211(6):1257-70.
93.Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy. 2023;8(1):200.
94.Singh N, Sharma S. Molecular and Immunological Mechanisms Associated with Diesel Exhaust Exposure. Targets [Internet]. 2025; 3(2).
95.Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduction and Targeted Therapy. 2023;8(1):204.
96.Zhou X, Dai H, Jiang H, Rui H, Liu W, Dong Z, et al. MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy. 2022;Volume 13 - 2022.
97.Hu Q, Bian Q, Rong D, Wang L, Song J, Huang H-S, et al. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. 2023;Volume 11 - 2023.
98.Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduction and Targeted Therapy. 2023;8(1):235.
99.Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM. Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. 2017;Volume 8 - 2017.
100.Woś I, Tabarkiewicz J. Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis. Immunologic research. 2021;69(1):26-42.
101.Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of toxicology. 2023;97(10):2499-574.
102.Honing DY, Luiten RM, Matos TR. Regulatory T Cell Dysfunction in Autoimmune Diseases. International journal of molecular sciences [Internet]. 2024; 25(13).
103.Mijač S, Banić I, Genc A-M, Lipej M, Turkalj M. The Effects of Environmental Exposure on Epigenetic Modifications in Allergic Diseases. Medicina [Internet]. 2024; 60(1).
104.Ramos-González EJ, Bitzer-Quintero OK, Ortiz G, Hernández-Cruz JJ, Ramírez-Jirano LJ. Relationship between inflammation and oxidative stress and its effect on multiple sclerosis. Neurología. 2024;39(3):292-301.
105.Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023-.
106.Canovas B, Nebreda AR. Diversity and versatility of p38 kinase signalling in health and disease. Nature Reviews Molecular Cell Biology. 2021;22(5):346-66.
107.He F, Ru X, Wen T. NRF2, a Transcription Factor for Stress Response and Beyond. International journal of molecular sciences. 2020;21(13).
108.Pant T, Uche N, Juric M, Zielonka J, Bai X. Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases. Redox Biology. 2024;70:103077.
109.Vogel CFA, Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors - Implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34:101530.
110.Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R. Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases. 2024;Volume 15 - 2024.
111.Vogel CFA, Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors – Implications for pollution mediated stress and inflammatory responses. Redox Biology. 2020;34:101530.
112.Wu Y-L, Lin Z-J, Li C-C, Lin X, Shan S-K, Guo B, et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduction and Targeted Therapy. 2023;8(1):98.
113.Mei X, Zhang B, Zhao M, Lu Q. An update on epigenetic regulation in autoimmune diseases. Journal of translational autoimmunity. 2022;5:100176.
114.Eghbalpour F, Aghaei M, Ebrahimi M, Tahsili M, Golalipour M, Mohammadi S, et al. Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay. Lupus. 2020;29:954-63.
115.Rider CF, Carlsten C. Air pollution and DNA methylation: effects of exposure in humans. Clinical Epigenetics. 2019;11(1):131.